Pharmaceuticals 

KPMG’s global Pharmaceuticals practice is dedicated to assisting businesses of all sizes from biotechnology start-ups to large multinational pharmaceutical companies.

Issues Monitor - Pharmaceuticals

Issues Monitor - Pharmaceuticals
It highlights the benefits & challenges with the adoption of technologies targeted to build efficiency in sales and marketing.

The Tablet - April 2011

The Tablet - April 2011

Comparative effectiveness research (CER) can represent a strategic opportunity for companies to develop a patient-centric business model designed to increase their competitive advantage and position themselves for future growth.

Ed Giniat

Ed Giniat

Global Chair, Pharmaceuticals

+1 (312) 665 2073

Our services are tailored to the issues that the industry ― and your company ― experience. Our member firms’ professionals have already helped many companies with these issues:

 

  • sales force compliance
  • pricing compliance
  • business model operating structure
  • operational efficiency
  • change management
  • supply chain management
  • fraud and intellectual property
  • innovation and research and development
  • competition from generics
  • mergers, acquisitions and disposals
  • market entry and expansion
  • emerging market companies.

 

KPMG’s industry-focused professionals have experience in the pharmaceutical sector; they continuously strive to keep abreast of industry trends, drivers and issues through knowledge sharing and industry insights programs. Our global network aims to ensure that KPMG firms serve you with the same level of quality and consideration, whether you are operating in fast growing or emerging markets in the Americas, Asia or Europe.

Sign up now

Subscribe to selected content and receive email alerts when new content is available for viewing on this site.

 

Already a member? Login

 

Not a member? Register